HGC Investment Management Inc. - EUCRATES BIOMEDICAL ACQU COR ownership

Back to all holdings Add to watchlist

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 5 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
HGC Investment Management Inc. ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q4 2022$793
-99.9%
79,1500.0%0.04%
-35.2%
Q3 2022$794,000
-49.6%
79,150
-50.0%
0.05%
+12.5%
Q2 2022$1,575,000
+101.7%
158,300
+100.0%
0.05%
+2.1%
Q1 2022$781,000–79,150–0.05%–
 Download
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q1 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 248,674$2,578,7491.28%
Verition Fund Management LLC 397,603$4,115,1910.06%
CLEAR STREET LLC 2,740$280.00%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1$100.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders